Shu-Jun Chiu

837 total citations
22 papers, 685 citations indexed

About

Shu-Jun Chiu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shu-Jun Chiu has authored 22 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Shu-Jun Chiu's work include Cancer-related Molecular Pathways (4 papers), Cancer Research and Treatments (3 papers) and MicroRNA in disease regulation (3 papers). Shu-Jun Chiu is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Cancer Research and Treatments (3 papers) and MicroRNA in disease regulation (3 papers). Shu-Jun Chiu collaborates with scholars based in Taiwan, United States and Ireland. Shu-Jun Chiu's co-authors include Yi‐Jang Lee, Pei‐Ming Yang, Lih‐Yuan Lin, Tzu-Sheng Hsu, Jui-Hung Yen, Jui‐I Chao, Ming‐Jiuan Wu, Chi‐Tang Ho, Szu‐Wei Huang and Pei‐Yi Chen and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Shu-Jun Chiu

22 papers receiving 674 citations

Peers

Shu-Jun Chiu
Rong Li China
Sarita G. Menon United States
Ji Hye Im South Korea
In-geun Ryoo South Korea
Germán A. Gil Argentina
Kaushik Datta United States
Rong Li China
Shu-Jun Chiu
Citations per year, relative to Shu-Jun Chiu Shu-Jun Chiu (= 1×) peers Rong Li

Countries citing papers authored by Shu-Jun Chiu

Since Specialization
Citations

This map shows the geographic impact of Shu-Jun Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Jun Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Jun Chiu more than expected).

Fields of papers citing papers by Shu-Jun Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-Jun Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Jun Chiu. The network helps show where Shu-Jun Chiu may publish in the future.

Co-authorship network of co-authors of Shu-Jun Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Jun Chiu. A scholar is included among the top collaborators of Shu-Jun Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Jun Chiu. Shu-Jun Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiu, Shu-Jun, et al.. (2024). Sclerostin and Cardiovascular Risk: Evaluating the Cardiovascular Safety of Romosozumab in Osteoporosis Treatment. Biomedicines. 12(12). 2880–2880. 3 indexed citations
2.
Wang, Boshen, et al.. (2016). Combining fisetin and ionizing radiation suppresses the growth of mammalian colorectal cancers in xenograft tumor models. Oncology Letters. 12(6). 4975–4982. 14 indexed citations
3.
Lin, Liang‐Ting, Shu-Jun Chiu, Hsin-Ell Wang, et al.. (2015). Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(5). 851–861. 44 indexed citations
4.
Yen, Chia-Jui, Yun‐Ju Chen, Shu-Jun Chiu, et al.. (2015). miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin. Oncotarget. 6(28). 25962–25974. 31 indexed citations
5.
Yang, Pei‐Ming, et al.. (2014). Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells. Autophagy. 10(7). 1212–1228. 64 indexed citations
6.
Lin, Liang‐Ting, Chih-Hsien Chang, Ren-Shyan Liu, et al.. (2014). Evaluation of the Therapeutic and Diagnostic Effects of PEGylated Liposome–Embedded 188Re on Human Non–Small Cell Lung Cancer Using an Orthotopic Small-Animal Model. Journal of Nuclear Medicine. 55(11). 1864–1870. 28 indexed citations
7.
Chiu, Shu-Jun, et al.. (2013). Enhanced cellular radiosensitivity induced by cofilin-1 over-expression is associated with reduced DNA repair capacity. International Journal of Radiation Biology. 89(6). 433–444. 13 indexed citations
8.
Lin, Liang‐Ting, Jyh‐Cheng Chen, Chien Chou, et al.. (2013). mPlum-IFP 1.4 fluorescent fusion protein may display Förster resonance energy transfer associated properties that can be used for near-infrared based reporter gene imaging. Journal of Biomedical Optics. 18(12). 126013–126013. 5 indexed citations
9.
Yang, Pei‐Ming, et al.. (2013). Radiation-induced senescence in securin-deficient cancer cells promotes cell invasion involving the IL-6/STAT3 and PDGF-BB/PDGFR pathways. Scientific Reports. 3(1). 1675–1675. 61 indexed citations
10.
Yang, Pei‐Ming, et al.. (2010). Securin depletion sensitizes human colon cancer cells to fisetin-induced apoptosis. Cancer Letters. 300(1). 96–104. 32 indexed citations
11.
Lee, Yi‐Jang, et al.. (2010). Enhancement of P53-Mutant Human Colorectal Cancer Cells Radiosensitivity by Flavonoid Fisetin. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1527–1535. 32 indexed citations
12.
Lee, Yi‐Jang, et al.. (2010). Depletion of Securin Induces Senescence After Irradiation and Enhances Radiosensitivity in Human Cancer Cells Regardless of Functional p53 Expression. International Journal of Radiation Oncology*Biology*Physics. 77(2). 566–574. 31 indexed citations
13.
14.
Chiu, Shu-Jun, et al.. (2009). Regulated expression of cofilin and the consequent regulation of p27kip1 are essential for G1 phase progression. Cell Cycle. 8(15). 2365–2374. 32 indexed citations
16.
Chiu, Shu-Jun, Jui‐I Chao, Yi‐Jang Lee, & Tzu-Sheng Hsu. (2008). Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells. Toxicology Letters. 179(2). 63–70. 48 indexed citations
17.
Chiu, Shu-Jun, Tzu-Sheng Hsu, & Jui‐I Chao. (2007). Expression of securin promotes colorectal cancer cell death via a p53-independent pathway after radiation. Chemico-Biological Interactions. 170(3). 153–161. 2 indexed citations
18.
Tsou, Tsui‐Chun, et al.. (2005). Inhibition of α7-nicotinic acetylcholine receptor expression by arsenite in the vascular endothelial cells. Toxicology Letters. 159(1). 47–59. 7 indexed citations
19.
Chiu, Shu-Jun, et al.. (2005). Differential Effects of Salen and Manganese-Salen Complex (EUK-8) on the Regulation of Cellular Cadmium Uptake and Toxicity. Toxicological Sciences. 85(1). 551–559. 10 indexed citations
20.
Chiu, Shu-Jun, et al.. (2004). Effect of cadmium on cell cycle progression in chinese hamster ovary cells. Chemico-Biological Interactions. 149(2-3). 125–136. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026